D
Diagnos Laboratorium Utama PT Tbk
IDX:DGNS
Diagnos Laboratorium Utama PT Tbk
IDX:DGNS
Price:
306
IDR
-1.29%
Market Closed
Market Cap:
Rp382.5B
Balance Sheet
Balance Sheet Decomposition
Diagnos Laboratorium Utama PT Tbk
Diagnos Laboratorium Utama PT Tbk
Balance Sheet Decomposition is not available for
Diagnos Laboratorium Utama PT Tbk
Diagnos Laboratorium Utama PT Tbk
Balance Sheet
Diagnos Laboratorium Utama PT Tbk
Diagnos Laboratorium Utama PT Tbk
Currency: IDR
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
1 303
|
1 537
|
1 393
|
16 538
|
44 720
|
28 011
|
10 245
|
4 209
|
|
| Cash |
1 303
|
1 537
|
1 393
|
16 538
|
44 720
|
28 011
|
10 245
|
4 209
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
6 507
|
2 543
|
1 696
|
960
|
|
| Total Receivables |
4 978
|
8 365
|
7 451
|
81 273
|
73 939
|
49 455
|
45 252
|
48 889
|
|
| Accounts Receivables |
4 951
|
8 321
|
7 433
|
50 816
|
41 730
|
42 422
|
38 280
|
41 810
|
|
| Other Receivables |
27
|
44
|
18
|
30 457
|
32 209
|
7 033
|
6 972
|
7 079
|
|
| Inventory |
928
|
1 074
|
2 123
|
5 813
|
7 760
|
6 567
|
5 142
|
5 043
|
|
| Other Current Assets |
0
|
160
|
452
|
1 530
|
20 938
|
31 798
|
25 470
|
19 507
|
|
| Total Current Assets |
7 210
|
11 136
|
11 420
|
105 154
|
153 864
|
118 373
|
87 805
|
78 608
|
|
| PP&E Net |
493
|
9 144
|
16 365
|
20 108
|
87 107
|
109 219
|
164 248
|
202 426
|
|
| PP&E Gross |
493
|
9 144
|
16 365
|
20 108
|
87 107
|
109 219
|
164 248
|
202 426
|
|
| Accumulated Depreciation |
217
|
626
|
2 882
|
6 724
|
13 813
|
27 047
|
30 100
|
43 397
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
681
|
720
|
1 353
|
|
| Note Receivable |
709
|
4 084
|
28 138
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
8 445
|
12 951
|
12 951
|
|
| Other Long-Term Assets |
76
|
74
|
3 300
|
7 313
|
1 012
|
3 218
|
5 750
|
4 685
|
|
| Total Assets |
8 488
N/A
|
24 439
+188%
|
59 222
+142%
|
132 575
+124%
|
241 983
+83%
|
239 936
-1%
|
271 475
+13%
|
300 022
+11%
|
|
| Liabilities | |||||||||
| Accounts Payable |
2 545
|
1 952
|
2 035
|
15 825
|
4 524
|
3 078
|
6 090
|
9 551
|
|
| Accrued Liabilities |
13
|
140
|
393
|
140
|
3 125
|
1 556
|
3 178
|
4 116
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
113
|
5 224
|
563
|
767
|
2 966
|
4 140
|
4 255
|
5 691
|
|
| Other Current Liabilities |
561
|
3 463
|
6 125
|
13 880
|
16 013
|
1 718
|
920
|
2 250
|
|
| Total Current Liabilities |
3 232
|
10 779
|
9 116
|
30 612
|
26 628
|
10 492
|
14 444
|
21 606
|
|
| Long-Term Debt |
1 757
|
98
|
3 127
|
2 188
|
10 451
|
17 330
|
59 285
|
73 172
|
|
| Deferred Income Tax |
0
|
0
|
7
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
281
|
296
|
512
|
708
|
3 103
|
1 686
|
2 156
|
9 112
|
|
| Total Liabilities |
5 270
N/A
|
11 173
+112%
|
12 763
+14%
|
33 508
+163%
|
40 182
+20%
|
29 508
-27%
|
75 885
+157%
|
103 890
+37%
|
|
| Equity | |||||||||
| Common Stock |
250
|
1 000
|
25 000
|
25 000
|
31 250
|
31 250
|
31 250
|
31 250
|
|
| Retained Earnings |
2 979
|
12 244
|
21 519
|
74 205
|
132 509
|
145 173
|
131 518
|
132 265
|
|
| Additional Paid In Capital |
29
|
29
|
29
|
29
|
36 707
|
36 707
|
36 707
|
36 707
|
|
| Other Equity |
40
|
7
|
88
|
168
|
1 335
|
2 702
|
3 884
|
4 090
|
|
| Total Equity |
3 218
N/A
|
13 266
+312%
|
46 459
+250%
|
99 066
+113%
|
201 800
+104%
|
210 428
+4%
|
195 590
-7%
|
196 132
+0%
|
|
| Total Liabilities & Equity |
8 488
N/A
|
24 439
+188%
|
59 222
+142%
|
132 575
+124%
|
241 983
+83%
|
239 936
-1%
|
271 475
+13%
|
300 022
+11%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
1 250
|
1 250
|
1 250
|
1 000
|
1 250
|
1 250
|
1 250
|
1 250
|
|
Switch to:
Switch to:
See Also
Discover More
